Genetic and Epigenetic Aspects of Type 1 Diabetes Mellitus: Modern View on the Problem

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2024 Feb 24

PMID 38398001

Authors

Ildar Minniakhmetov

Bulat Yalaev

Rita Khusainova

Ekaterina Bondarenko

Galina Melnichenko

Ivan Dedov

Natalia Mokrysheva

Affiliations

Soon will be listed here.

Abstract

Omics technologies accumulated an enormous amount of data that advanced knowledge about the molecular pathogenesis of type 1 diabetes mellitus and identified a number of fundamental problems focused on the transition to personalized diabetology in the future. Among them, the most significant are the following: (1) clinical and genetic heterogeneity of type 1 diabetes mellitus; (2) the prognostic significance of DNA markers beyond the genes; (3) assessment of the contribution of a large number of DNA markers to the polygenic risk of disease progress; (4) the existence of ethnic population differences in the distribution of frequencies of risk alleles and genotypes; (5) the infancy of epigenetic research into type 1 diabetes mellitus. Disclosure of these issues is one of the priorities of fundamental diabetology and practical healthcare. The purpose of this review is the systemization of the results of modern molecular genetic, transcriptomic, and epigenetic investigations of type 1 diabetes mellitus in general, as well as its individual forms. The paper summarizes data on the role of risk haplotypes and a number of other candidate genes and loci, identified through genome-wide association studies, in the development of this disease and in alterations in T cell signaling. In addition, this review assesses the contribution of differential DNA methylation and the role of microRNAs in the formation of the molecular pathogenesis of type 1 diabetes mellitus, as well as discusses the most currently central trends in the context of early diagnosis of type 1 diabetes mellitus.

Citing Articles

Major heme proteins hemoglobin and myoglobin with respect to their roles in oxidative stress - a brief review.

Sil R, Chakraborti A Front Chem. 2025; 13:1543455.

PMID: 40070406 PMC: 11893434. DOI: 10.3389/fchem.2025.1543455.

Pathogenetic therapeutic approaches for endocrine diseases based on antisense oligonucleotides and RNA-interference.

Golounina O, Minniakhmetov I, Salakhov R, Khusainova R, Zakharova E, Bychkov I Front Endocrinol (Lausanne). 2025; 16:1525373.

PMID: 39944202 PMC: 11813780. DOI: 10.3389/fendo.2025.1525373.

Unravelling the Role of Gut and Oral Microbiota in the Pediatric Population with Type 1 Diabetes Mellitus.

Luppi S, Aldegheri L, Azzalini E, Pacetti E, Barucca Sebastiani G, Fabiani C Int J Mol Sci. 2024; 25(19).

PMID: 39408940 PMC: 11477131. DOI: 10.3390/ijms251910611.

References

Redondo M, Gignoux C, Dabelea D, Hagopian W, Onengut-Gumuscu S, Oram R . Type 1 diabetes in diverse ancestries and the use of genetic risk scores. Lancet Diabetes Endocrinol. 2022; 10(8):597-608. PMC: 10024251. DOI: 10.1016/S2213-8587(22)00159-0. View

Marroqui L, Dos Santos R, Floyel T, Grieco F, Santin I, Op de Beeck A . TYK2, a Candidate Gene for Type 1 Diabetes, Modulates Apoptosis and the Innate Immune Response in Human Pancreatic β-Cells. Diabetes. 2015; 64(11):3808-17. DOI: 10.2337/db15-0362. View

Srinivasan S, Wu P, Mercader J, Udler M, Porneala B, Bartz T . A Type 1 Diabetes Polygenic Score Is Not Associated With Prevalent Type 2 Diabetes in Large Population Studies. J Endocr Soc. 2023; 7(11):bvad123. PMC: 10576255. DOI: 10.1210/jendso/bvad123. View

Benoist C, Mathis D . Autoimmune diabetes. Retrovirus as trigger, precipitator or marker?. Nature. 1997; 388(6645):833-4. DOI: 10.1038/42145. View

Margaritis K, Margioula-Siarkou G, Giza S, Kotanidou E, Tsinopoulou V, Christoforidis A . Micro-RNA Implications in Type-1 Diabetes Mellitus: A Review of Literature. Int J Mol Sci. 2021; 22(22). PMC: 8621893. DOI: 10.3390/ijms222212165. View

Hu X, Deutsch A, Lenz T, Onengut-Gumuscu S, Han B, Chen W . Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk. Nat Genet. 2015; 47(8):898-905. PMC: 4930791. DOI: 10.1038/ng.3353. View

Bansal A, Pinney S . DNA methylation and its role in the pathogenesis of diabetes. Pediatr Diabetes. 2017; 18(3):167-177. PMC: 5394941. DOI: 10.1111/pedi.12521. View

Dilthey A, Gourraud P, Mentzer A, Cereb N, Iqbal Z, McVean G . High-Accuracy HLA Type Inference from Whole-Genome Sequencing Data Using Population Reference Graphs. PLoS Comput Biol. 2016; 12(10):e1005151. PMC: 5085092. DOI: 10.1371/journal.pcbi.1005151. View

Hagopian W, Erlich H, Lernmark A, Rewers M, Ziegler A, Simell O . The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes. 2011; 12(8):733-43. PMC: 3315186. DOI: 10.1111/j.1399-5448.2011.00774.x. View

10.

Barrett J, Clayton D, Concannon P, Akolkar B, Cooper J, Erlich H . Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009; 41(6):703-7. PMC: 2889014. DOI: 10.1038/ng.381. View

11.

Lakhter A, Pratt R, Moore R, Doucette K, Maier B, DiMeglio L . Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes. Diabetologia. 2018; 61(5):1124-1134. PMC: 5878132. DOI: 10.1007/s00125-018-4559-5. View

12.

Floyel T, Brorsson C, Nielsen L, Miani M, Bang-Berthelsen C, Friedrichsen M . CTSH regulates β-cell function and disease progression in newly diagnosed type 1 diabetes patients. Proc Natl Acad Sci U S A. 2014; 111(28):10305-10. PMC: 4104872. DOI: 10.1073/pnas.1402571111. View

13.

Kavvoura F, Ioannidis J . CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a HuGE Review and meta-analysis. Am J Epidemiol. 2005; 162(1):3-16. DOI: 10.1093/aje/kwi165. View

14.

Lawrence J, Divers J, Isom S, Saydah S, Imperatore G, Pihoker C . Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001-2017. JAMA. 2021; 326(8):717-727. PMC: 8385600. DOI: 10.1001/jama.2021.11165. View

15.

Senee V, Chelala C, Duchatelet S, Feng D, Blanc H, Cossec J . Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet. 2006; 38(6):682-7. DOI: 10.1038/ng1802. View

16.

Stankov K, Benc D, Draskovic D . Genetic and epigenetic factors in etiology of diabetes mellitus type 1. Pediatrics. 2013; 132(6):1112-22. DOI: 10.1542/peds.2013-1652. View

17.

Harrison J, Tallapragada D, Baptist A, Sharp S, Bhaskar S, Jog K . Type 1 diabetes genetic risk score is discriminative of diabetes in non-Europeans: evidence from a study in India. Sci Rep. 2020; 10(1):9450. PMC: 7289794. DOI: 10.1038/s41598-020-65317-1. View

18.

Smyth D, Cooper J, Howson J, Clarke P, Downes K, Mistry T . FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection. Diabetes. 2011; 60(11):3081-4. PMC: 3198057. DOI: 10.2337/db11-0638. View

19.

Leslie R, Kolb H, Schloot N, Buzzetti R, Mauricio D, de Leiva A . Diabetes classification: grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev. 2008; 24(7):511-9. DOI: 10.1002/dmrr.877. View

20.

Skyler J, Greenbaum C, Lachin J, Leschek E, Rafkin-Mervis L, Savage P . Type 1 Diabetes TrialNet--an international collaborative clinical trials network. Ann N Y Acad Sci. 2009; 1150:14-24. PMC: 2918900. DOI: 10.1196/annals.1447.054. View